HGH Fragment 176-191 Peptide, raws li ib qho tshwj xeeb C-terminal fragment ntawm tib neeg kev loj hlob hormone (HGH), txawv los ntawm cov multifunctional, broad -spectrum cuam tshuam ntawm qhov tsis zoo cov tshuaj hormones loj hlob. Tsis tsuas yog nws muaj lub hom phiaj tswj cov khoom rau lipid metabolize, tab sis nws kuj qhia tau qhov zoo ntawm kev cuam tshuam ntawm metabolic ntshawv siab - nws cov molecular tshwj xeeb thiab qis qis - cov txiaj ntsig tuaj yeem tswj hwm lub cev metabolic homeostasis, tiv thaiv kev ua haujlwm ntawm cov kab mob metabolic tseem ceeb, thiab zam kev cuam tshuam cov metabolic. Qhov no ua rau muaj kev cuam tshuam tsawg - cuam tshuam, siab - kev nyab xeeb tus neeg sib tw kev taw qhia rau kev tshawb fawb tshawb fawb txog cov kab mob metabolic. Tib lub sijhawm, nws txoj haujlwm tswj hwm hauv lipid metabolize tuaj yeem pab txhim kho cov teeb meem rog rog txuam nrog cov teeb meem metabolic. Hauv qab no, peb yuav muab cov ncauj lus kom ntxaws txog nws cov teebmeem tshwj xeeb ntawm kev txo cov rog rog thiab cov kab mob metabolic, nrog rau kev tsom mus rau kev nthuav qhia nws cov txiaj ntsig tseem ceeb hauv kev cuam tshuam metabolic.
Peb cov khoom ua qauv qhia
HGH 176-191 COA
 |
||
| Certificate of Analysis | ||
| Compound npe | HWV 176-191 | |
| Qib | Pharmaceutical qib | |
| CAS Nr. | 66004-57-7 | |
| Ntau | 35g | |
| Ntim txheem | PE hnab + Al foil hnab | |
| Chaw tsim tshuaj paus | Shaanxi BLOOM TECH Co., Ltd | |
| Ntau No. | 202501090086 | |
| MFG | Peb 9, 2025 | |
| EXP | Peb 8, 2028 | |
| Qauv |
|
|
| Yam khoom | Enterprise txheem | Kev txheeb xyuas qhov tshwm sim |
| Qhov tshwm sim | Dawb los yog yuav luag dawb hmoov | Ua raws |
| Cov ntsiab lus dej | Tsawg dua lossis sib npaug li 5.0% | 0.54% |
| Poob rau ziab | Tsawg dua lossis sib npaug li 1.0% | 0.42% |
| Hnyav Hlau | Pb Tsawg dua lossis sib npaug li 0.5ppm | N.D. |
| Tsawg dua lossis sib npaug li 0.5ppm | N.D. | |
| Hg Tsawg dua lossis sib npaug li 0.5ppm | N.D. | |
| Cd Tsawg dua lossis sib npaug li 0.5ppm | N.D. | |
| Purity (HPLC) | Ntau dua lossis sib npaug li 99.0% | 99.90% |
| Ib qho impurity | <0.8% | 0.52% |
| Tag nrho microbial suav | Tsawg dua lossis sib npaug li 750cfu / g | 95 |
| E. Coli | Tsawg dua lossis sib npaug li 2MPN / g | N.D. |
| Salmonella | N.D. | N.D. |
| Ethanol (los ntawm GC) | Tsawg dua lossis sib npaug li 5000ppm | 500ppm ua |
| Cia | Khaws rau hauv qhov chaw kaw, tsaus, thiab qhuav hauv qab -20 degree | |
|
|
||
Precisely tswj kev poob phaus ntawm qib molecular
Kev poob phaus ua haujlwm ntawm cov tshuaj no yog nws cov yam ntxwv tseem ceeb tshaj plaws, thiab nws muaj qhov zoo ntawm cov txheej txheem ntawm kev ua, lub hom phiaj, kev nyab xeeb, thiab lwm yam, qhov txawv ntawm qhov tsis zoo ntawm cov tshuaj hormones loj hlob (hGH) thiab cov qauv kev poob phaus.
Kev rog rog yog inhibited los ntawm ob qhov kev xav: "txo cov rog rog" thiab "thaiv kev rog rog":
Inhibition ntawm preadipocyte sib txawv: Thaiv kev hloov pauv ntawm fibroblast-zoo li preadipocytes rau hauv cov adipocytes paub tab, txo tag nrho cov adipocytes thiab txo cov rog rog ntawm qhov chaw.
Inhibition ntawm fatty acid synthesis: Downregulates qhov kev qhia ntawm cov enzymes tseem ceeb xws li fatty acid synthase (FAS) thiab acetyl-CoA carboxylase (ACC), txo qhov tsim ntawm endogenous fatty acids.
Blockade of fat uptake thiab deposition: Inhibits the uptake of glucose and free fatty acids from the bloodstream by adipocytes thaum txo cov re-synthesis thiab cia triglycerides hauv adipocytes, tiv thaiv "fat re-sau."
(II) Reprogramming Zog Supersession: Ua ntej siv roj rau lub zog
Txhim kho ntawm basal metabolic rate (BMR): Los ntawm kev tswj cov mitochondrial muaj nuj nqi, txhawb cov fatty acid oxidation nyob rau hauv adipose thiab puissance cov ntaub so ntswg, ua kom lub zog siv nyiaj thaum so thiab tiv thaiv lub zog dhau los ntawm kev hloov mus rau hauv rog.
Kev ua kom zoo ntawm cov khoom siv hluav taws xob zoo: Thaum lub sijhawm ua haujlwm lossis lub zog tsis muaj zog, ua qhov tseem ceeb ntawm kev sib koom ua ke ntawm cov rog tawg rau lub zog, txo qis kev noj ntawm puissance glycogen thiab ua tiav cov qauv metabolic ntawm "qhov hnyav poob thaum khaws cia puissance".
Kev txhim kho ntawm cov ntshav lipid supersession: Txo cov triglycerides thiab qis- ntom lipoprotein cholesterol (LDL-C) hauv cov ntshav thaum nce siab -cov roj lipoprotein ceev (HDL{3}}C), txo cov lipids tso rau hauv cov hlab ntsha thiab kev tiv thaiv visceral.
Qhov tseeb ntawm Cov Tshuaj "tsuas yog txo kev rog, tsis cuam tshuam rau tag nrho lub cev"
Tus nqi tseem ceeb ntawm qhov no yog nyob rau hauv nws qhov kev ua tiav dhau qhov kev txwv ntawm cov roj ib txwm muaj- kev cuam tshuam poob, uas feem ntau cuam tshuam nrog "system- cuam tshuam thoob plaws thiab ntau- phiaj xwm cuam tshuam." Hloov chaw, nws ua tiav lub hom phiaj meej ntawm qib molecular thiab siab tshwj xeeb hauv cov txiaj ntsig ua haujlwm. Qhov no tsis yog tsuas yog ua kom muaj roj- poob kev ua tau zoo tab sis kuj tseem ua kom tsis txhob cuam tshuam nrog cov tsis yog - cov ntaub so ntswg lossis lub luag haujlwm. Cov yam ntxwv no yog qhov tseem ceeb uas txawv ntawm qhov tsis zoo ntawm tib neeg txoj kev loj hlob hormone (hGH), cov rog ib txwm siv -cov tshuaj poob, thiab lwm yam metabolic- tswj peptides.
Kev lees paub meej ntawm qib Receptor: Ua kom tsuas yog Adipocyte nkaus xwb -Specific Receptors, Tsis muaj khi rau Kev Loj Hlob Hormone Receptors (GHR)
Cov ntaub so ntswg- lub hom phiaj muaj peev xwm ntawm nws hauv paus pib los ntawm nws qhov nqaim heev receptor-binding profile, uas yog qhov sib txawv ntawm qhov tsis zoo ntawm hGH: Receptor Generalization ntawm Intact hGH: Intact hGH exerts nws cov teebmeem los ntawm kev khi rau cov ntaub so ntswg loj hlob, yuav luag tag nrho cov ntaub so ntswg receptors (GHR), pob txha, pob txha mos, lub cev tiv thaiv kab mob, thiab adipocytes.
Yog li ntawd, hGH ib txhij ua rau muaj kev cuam tshuam ntau yam hauv lub cev, xws li kev loj hlob, kev hloov pauv, kev tiv thaiv kab mob, thiab kev loj hlob, ua rau nws tsis tuaj yeem ua tiav "rog-tsuas yog lub hom phiaj."
Receptor Specification ntawm qhov no: Qhov no tsis khi rau GHR txhua. Hloov chaw, nws tshwj xeeb lees paub thiab ua kom 3-adrenergic receptors (3-AR), uas tau nthuav tawm heev ntawm daim nyias nyias ntawm adipocytes. Qhov no yog lub hauv paus molecular rau nws cov ntaub so ntswg tsom.
3-AR yog ib hom G protein-coupled receptor nrog kev txwv kev faib tawm ntawm lub cev:
Siab - Cov Chaw Qhia Txog: Feem ntau yog concentrated nyob rau hauv cov adipocytes dawb (subcutaneous thiab visceral rog) thiab tsawg dua nyob rau hauv cov xim av adipocytes, ua 3-AR ib tug functionality receptor rau cov ntaub so ntswg adipose.
Tsawg / Tsis muaj- Cov Chaw Qhia: Hauv cov hlwb pob txha (skeletal thiab plawv puissance), hepatocytes, pancreatic islet cells, endocrine glands (xws li cov thyroid thiab adrenal glands), pob txha hlwb, thiab lub cev tiv thaiv kab mob, 3-AR kev qhia yog qhov qis heev los yog tsis muaj kiag li. Yog li ntawd, cov ntaub so ntswg tsis tuaj yeem ua haujlwm zoo los ntawm cov tshuaj no.
Qhov no yog -rau- ib qho kev sib txuas lus ntawm "receptor thiab cov ntaub so ntswg" ua kom ntseeg tau tias cov tshuaj no tsuas tuaj yeem pib qhia txoj hauv kev hauv adipocytes. Nws tsis tuaj yeem siv cov tshuaj pharmacological ncaj qha rau cov uas tsis yog- cov ntaub so ntswg adipose, yog li tshem tawm cov ntoo khaub lig-cov ntaub so ntswg "tawm- cov phiaj xwm" ntawm qhov chaw.
Kev cuam tshuam zoo rau cov kab mob metabolic
HGH Fragment176-191Ua kom pom qhov zoo tshwj xeeb hauv kev cuam tshuam hauv cov kab mob metabolic, feem ntau pom hauv nws qhov kev cuam tshuam qis rau cov kab mob metabolic homeostasis, nws tiv thaiv cov teebmeem ntawm cov core metabolic axes, thiab nws lub peev xwm los zam ntau yam -dimensional metabolic imbalances. Cov yam ntxwv no tau paub qhov txawv ntawm tib neeg txoj kev loj hlob hormone (HGH) thiab lwm yam kev tswj hwm cov metabolism. Kev tshuaj xyuas hauv qab no piav qhia txog cov txiaj ntsig zoo los ntawm qhov tsis yog - txo qis lipid foundations.
I. Tswj Glucose Metabolic Homeostasis thiab zam kev pheej hmoo ntawm Glucose Supersession Disorders
Intact HGH cuam tshuam nrog cov kev cai tswj hwm cov piam thaj tseem ceeb los ntawm kev ua kom muaj kev loj hlob hormone receptors (GHR), uas tau nthuav dav thoob plaws hauv lub cev. Hauv qhov sib piv, qhov no tag nrho zam cov teeb meem ntawm qib molecular, ua rau nws muaj txiaj ntsig zoo hauv cov teeb meem metabolic:
Tsis muaj kev cuam tshuam ntawm Insulin Signaling Pathways
Cov tshuaj no tsis khi rau GHR, yog li zam qhov qis qis qis uas tuaj yeem cuam tshuam cov tshuaj insulin receptors. Nws kuj tsis cuam tshuam rau kev sib khi ua haujlwm ntawm insulin rau lub hom phiaj ntawm cov receptors lossis cov teeb liab hloov pauv hauv lub cev. Qhov no khaws cia cov kev ua haujlwm ntawm lub cev ntawm cov tshuaj insulin- nruab nrab ntawm cov piam thaj hauv cov ntshav, kev siv, thiab kev khaws cia, tiv thaiv cov ntshav qabzib hauv lub cev xws li txo qis insulin rhiab heev thiab tiv thaiv insulin. Yog li ntawd, nws tsis muaj kev cuam tshuam tsis zoo rau cov piam thaj metabolic homeostasis.
Tsis cuam tshuam nrog Key Hepatic Glucose Supersession Functions
Lub siab yog lub hauv paus tseem ceeb rau kev noj qab haus huv. Thaum tsis muaj HGH abnormality activates hepatic gluconeogenesis txoj hauv kev thiab inhibits glycogen synthesis - ua rau kom siab ceev cov ntshav qabzib thiab impaired qabzib siab ntev - cov tshuaj no tsis ua rau cov metabolic receptors nyob rau hauv hepatocytes.
Nws tsis tswj cov kev ua ntawm tus nqi - txwv cov enzymes hauv hepatic gluconeogenesis lossis cuam tshuam rau kev sib xyaw ua ke ntawm lub siab thiab kev ua kom lub siab glycogen.Qhov no tswj lub siab lub cev muaj peev xwm tswj cov ntshav qabzib thiab tshem tawm cov peev xwm rau daim siab - ntxias cov piam thaj hloov pauv.
Tsis muaj qhov cuam tshuam thib ob los ntawm qhov txawv txav ntawm cov ntshav qabzib hloov pauv
Cov txheej txheem ntawm cov tshuaj no tsis koom nrog hauv nruab nrab lossis peripheral txoj hauv kev ntawm kev tswj ntshav qabzib. Nws tsis ua rau kev yoo mov hyperglycemia lossis ua rau cov ntshav qabzib tsis zoo tom qab nce siab lossis muaj kev pheej hmoo hypoglycemia.
Los ntawm kev zam kom tsis txhob muaj cov piam thaj hauv cov ntshav hloov pauv, nws tiv thaiv cov metabolic cascades tshwm sim los ntawm qhov tsis sib xws, xws li nce oxidative kev nyuaj siab thiab cuam tshuam kev faib cov metabolic substrates.Qhov no ua rau muaj kev pheej hmoo tsawg - lub hauv paus muaj kev pheej hmoo rau kev cuam tshuam metabolic hauv cov tib neeg uas muaj cov piam thaj supersession txawv txav.
II. Txhim kho Homeostasis ntawm Endocrine Metabolic Axes thiab txo qis Metabolic Disorders
Cov kab mob metabolic feem ntau yog nrog los ntawm endocrine axis imbalances. Cov peptide no tsis cuam tshuam ncaj qha rau lub cev lub cev tseem ceeb hauv endocrine metabolic axes, yog li zam qhov teeb meem ntawm "kev cuam tshuam ua rau cov kab mob metabolic tshiab"-ib qho txiaj ntsig tseem ceeb ntawm qhov sib txawv ntawm cov txheej txheem metabolic feem ntau.
Tsis muaj kev cuam tshuam ntawm Hypothalamic-Pituitary-Target Gland Axis Function
Intact HGH tuaj yeem tawm tswv yim thiab cuam tshuam rau kev tso tawm ntawm hypothalamic kev loj hlob hormone- tso tawm cov tshuaj hormones thiab somatostatin, tsis ncaj qha cuam tshuam cov hormonal secretion rhythms ntawm cov qog lub hom phiaj xws li thyroid, adrenal, thiab gonadal qog, yog li ua rau ntau yam -glandular metabolic ntshawv siab. Nyob rau hauv sib piv, no peptide tsis koom nyob rau hauv lub tswv yim kev tswj loops ntawm lub hypothalamic -pituitary axis thiab tsis muaj kev cuam tshuam rau lub secretion ntawm tseem ceeb metabolic regulatory cov tshuaj hormones xws li thyroid- stimulating hormone, adrenocorticotropic hormone, thiab poj niam txiv neej cov tshuaj hormones. Nws yog li tswj hwm lub cev sib npaug ntawm hypothalamic-pituitary- lub hom phiaj gland axis, tiv thaiv cov kab mob endocrine metabolic thib ob.
Tsis muaj Induction ntawm Dej -Electrolyte lossis Fluid Balance Disorders
Intact HGH txhawb nqa sodium thiab dej reabsorption nyob rau hauv lub distal convoluted tubules ntawm ob lub raum, ua rau dej thiab sodium retention, txawv txav ntawm cov ntshav, thiab tom qab cov ntshav siab hloov pauv thiab cov kua dej supersession imbalances, yog li exacerbating cardiovascular metabolic txaus ntshai cuam tshuam nrog metabolic ntshawv siab. Cov peptide no tsis ua rau lub raum receptors koom nrog hauv dej -electrolyte metabolize thiab tsis cuam tshuam rau kev ua ntawm aldosterone lossis antidiuretic hormone. Nws tswj cov metabolize ib txwm thiab tso tawm ntawm cov electrolytes xws li dej, sodium, thiab potassium, yog li tsis txhob haus dej cawv metabolism thiab lwm yam kab mob plawv metabolic.
Tsis muaj qhov txawv txav ntawm Supersession-Cov tshuaj Hormone secretion
Nws cov txheej txheem tsis koom nrog kev tswj hwm ntawm cov tshuaj hormones metabolic uas tsis yog leptin, adiponectin, thiab ghrelin (tsis yog nws ua rau muaj kev cuam tshuam los ntawm cov tshuaj hormones). Nws tsis txawv txav ntawm qhov tso tawm ntawm cov piam thaj-nce thiab supersession - cuam tshuam cov tshuaj hormones xws li cortisol lossis glucagon, thiab nws tsis cuam tshuam cov tshuaj hormones tseem ceeb uas tswj cov metabolism hauv homeostasis, xws li insulin thiab thyroxine. Qhov no khaws cia lub physiological atherosclerosis ntawm systemic metabolic hormone secretion.
FAQ
- Dab tsi yog cov cim qhia tias HGH ua haujlwm?
Nyob rau ob peb lub hlis tom ntej no, koj pib pom kev hloov pauv ntau dua. Cov no suav nrog kev txhim kho puissance tone, txo lub cev rog, thiab nce lean puissance loj. Kev kho HGH kuj tuaj yeem txhim kho daim tawv nqaij elasticity. HGH peptide therapy tuaj yeem ua tau ntev -kev kho mob, nyob ntawm koj lub hom phiaj kev noj qab haus huv.
- Puas yog HGH ua rau koj zoo li hluas?
Qee cov neeg thov tias kev siv HGH tuaj yeem ncua qee qhov kev hloov pauv txuas rau kev laus, xws li tsis muaj zog thiab pob txha loj. Yog tias koj tsis ntseeg, zoo. Muaj kev tshawb fawb me me los qhia tias HGH tuaj yeem pab cov neeg laus noj qab haus huv rov qab los rau cov hluas thiab lub zog.
Cim npe nrov: Tuam Tshoj Hgh Fragment 176-191 peptide manufacturers, lwm tus neeg
